1. Home
  2. TVTX vs NG Comparison

TVTX vs NG Comparison

Compare TVTX & NG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVTX
  • NG
  • Stock Information
  • Founded
  • TVTX 2008
  • NG 1984
  • Country
  • TVTX United States
  • NG Canada
  • Employees
  • TVTX N/A
  • NG N/A
  • Industry
  • TVTX Biotechnology: Pharmaceutical Preparations
  • NG Precious Metals
  • Sector
  • TVTX Health Care
  • NG Basic Materials
  • Exchange
  • TVTX Nasdaq
  • NG Nasdaq
  • Market Cap
  • TVTX 1.4B
  • NG 1.5B
  • IPO Year
  • TVTX N/A
  • NG N/A
  • Fundamental
  • Price
  • TVTX $15.63
  • NG $5.26
  • Analyst Decision
  • TVTX Strong Buy
  • NG Strong Buy
  • Analyst Count
  • TVTX 16
  • NG 2
  • Target Price
  • TVTX $33.33
  • NG $7.00
  • AVG Volume (30 Days)
  • TVTX 1.2M
  • NG 3.0M
  • Earning Date
  • TVTX 08-06-2025
  • NG 06-25-2025
  • Dividend Yield
  • TVTX N/A
  • NG N/A
  • EPS Growth
  • TVTX N/A
  • NG N/A
  • EPS
  • TVTX N/A
  • NG N/A
  • Revenue
  • TVTX $273,533,000.00
  • NG N/A
  • Revenue This Year
  • TVTX $71.61
  • NG N/A
  • Revenue Next Year
  • TVTX $43.45
  • NG N/A
  • P/E Ratio
  • TVTX N/A
  • NG N/A
  • Revenue Growth
  • TVTX 75.65
  • NG N/A
  • 52 Week Low
  • TVTX $7.93
  • NG $2.26
  • 52 Week High
  • TVTX $25.29
  • NG $6.16
  • Technical
  • Relative Strength Index (RSI)
  • TVTX 49.00
  • NG 56.37
  • Support Level
  • TVTX $15.28
  • NG $5.07
  • Resistance Level
  • TVTX $15.97
  • NG $5.40
  • Average True Range (ATR)
  • TVTX 0.62
  • NG 0.28
  • MACD
  • TVTX -0.06
  • NG -0.07
  • Stochastic Oscillator
  • TVTX 28.78
  • NG 31.82

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

About NG Novagold Resources Inc.

Novagold Resources Inc operates in the gold mining industry, focused on advancing the Donlin Gold project in Alaska. The Donlin Gold project is held by Donlin Gold LLC (Donlin Gold), a limited liability company owned equally by wholly owned subsidiaries of NOVAGOLD and Barrick Gold Corporation (Barrick). The company includes exploration and development activities of gold and other presious metals.

Share on Social Networks: